SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2,998.84 |
Enterprise Value ($M) | 2,559.98 |
Book Value ($M) | 431.75 |
Book Value / Share | 2.62 |
Price / Book | 6.95 |
NCAV ($M) | 298.92 |
NCAV / Share | 1.81 |
Price / NCAV | 10.03 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.13 |
Return on Assets (ROA) | -0.10 |
Return on Equity (ROE) | -0.15 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.28 |
Current Ratio | 2.42 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 616.12 |
Assets | 748.96 |
Liabilities | 317.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 726.44 |
Operating Income | -73.38 |
Net Income | -61.29 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 16.70 |
Cash from Investing | 32.00 |
Cash from Financing | 25.13 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Rtw Investments, Lp | 6.90 | ||
13G/A | Vanguard Group Inc | 8.16 | 0.88 | |
13G/A | Fmr Llc | 3.21 | -43.59 | |
13G/A | BlackRock Inc. | 6.90 | 11.21 | |
13D/A | Baker Bros. Advisors Lp | 26.50 | 2.18 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
178,694 | 1,318,298 | 13.55 | |
165,022 | 1,445,409 | 11.42 | |
498,477 | 1,845,162 | 27.02 | |
159,629 | 1,480,951 | 10.78 | |
(click for more detail) |
Similar Companies | |
---|---|
ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
ABUS – Arbutus Biopharma Corporation | ACLX – Arcellx, Inc. |
ACOR – Acorda Therapeutics, Inc. |